Aclaris Therapeutics (NASDAQ:ACRS) Now Covered by StockNews.com
Investment analysts at StockNews.com assumed coverage on shares of Aclaris Therapeutics (NASDAQ:ACRS – Get Free Report) in a research note issued on Thursday. The firm set a “sell” rating on the biotechnology company’s stock. A number of other research firms have also issued reports on ACRS. HC Wainwright reiterated a “buy” rating and set a […]